Clinical Trial Update: Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl

View source ↗

Summary

A clinical trial evaluating beta-amyloid PET imaging for Alzheimer's disease using the radiotracer [18F]-Fluselenamyl is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• [18F]-Fluselenamyl (Fluselenamyl)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimer Disease | Status: RECRUITING